By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


Big Pharma


CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.


Maxygen, Inc. 

Intergen Company 

Company News
Xybion Announces That Novo Nordisk A/S (NVO) Selects Pristima To Manage Pharmacology Research Studies Across All Research Sites 10/1/2015 11:03:45 AM
Novo Nordisk A/S (NVO) Launches New Medical Resource For People Living With Hemophilia And Other Rare Bleeding Disorders 9/29/2015 10:48:57 AM
Novo Nordisk A/S (NVO) Finally Bags Diabetes Drug Tresiba U.S. Approval 9/28/2015 6:07:56 AM
Novo Nordisk A/S (NVO) New Plant In Iran – How Will The Local Production Of Insulin Impact The Pharma Market? 9/24/2015 10:08:38 AM
Novo Nordisk A/S (NVO) to Build $78 Million Plant in Iran 9/22/2015 6:32:28 AM
Novo Nordisk A/S (NVO)’s Victoza Beats Sanofi (SNY)’s Lixisenatide in Head-to-Head Study, Company Says 9/16/2015 10:20:09 AM
Analysts Bet Novo Nordisk A/S (NVO)'s Insulin Drug Will Get FDA Approval 9/15/2015 10:35:28 AM
A Day After Investing $1.7 Billion in North Carolina, Novo Nordisk A/S (NVO) Buys Two Indiana Biotech Companies 8/28/2015 6:05:43 AM
Novo Nordisk A/S (NVO) Pulls the Plug on Expanding Victoza for Type 1 Diabetes 8/27/2015 6:40:42 AM
Novo Nordisk A/S (NVO) to Invest $1.2 to $1.7 Billion in North Carolina and Create 700 Jobs 8/26/2015 1:51:11 PM